Onset of secondary progressive MS after long‐term rituximab therapy – a case report

A patient with relapsing multiple sclerosis (RMS) was treated with a standard immunomodulatory therapy, but due to ongoing disease activity was switched to rituximab. Relapses ceased, but secondary progressive MS (SPMS) eventually appeared, associated with new focal spinal cord white matter lesions....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Clin Transl Neurol
Main Authors: von Büdingen, H.‐Christian, Bischof, Antje, Eggers, Erica L., Wang, Shengzhi, Bevan, Carolyn J., Cree, Bruce A. C., Henry, Roland G., Hauser, Stephen L.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2016
Assuntos:
Brief Communication
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5221476/
https://ncbi.nlm.nih.gov/pubmed/28078314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.377
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares